An updated review in 2019 reported increasing levels of IL-6, TNF-α, and IL-1β in different groups of patients, including first-time psychosis without medication and patients with first-time psychosis who were often treated with antipsychotics and chronic patients and patients with acute recurrence [42]. This evidence concerns the gene TNF and psychotic disorder.